(Q44426118)

2 December 2017

Addition of Rosiglitazone to Existing Sulfonylurea Treatment in Chinese Patients with Type 2 Diabetes and Exposure to Hepatitis B or C (English)

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

29 December 2023

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

29 December 2023

author name string

Zhu XX

1

1 reference

2 December 2017

Pan CY

2

1 reference

2 December 2017

Li GW

3

1 reference

2 December 2017

Shi HL

4

1 reference

2 December 2017

Yang WY

6

1 reference

2 December 2017

Sun XC

8

1 reference

2 December 2017

Chow WH

10

1 reference

2 December 2017

X-X Zhu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725705

29 December 2023

C-Y Pan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725705

29 December 2023

G-W Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725705

29 December 2023

H-L Shi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725705

29 December 2023

H. Tian

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725705

29 December 2023

W-Y Yang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725705

29 December 2023

J. Jiang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725705

29 December 2023

X-C Sun

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725705

29 December 2023

C. Davies

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725705

29 December 2023

W-H Chow

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12725705

29 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12725705

29 December 2023

publication date

1 January 2003

1 reference

full work available at URL

2 December 2017

http://www.liebertpub.com/doi/pdf/10.1089/152091503763816445

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Diabetes technology & therapeutics

29 December 2023

published in

1 reference

2 December 2017

5

1 reference

2 December 2017

1

1 reference

2 December 2017

33-42

1 reference

Section Review: Oncologic, Endocrine & Metabolic: Thiazolidinediones

2 December 2017

1

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

A novel antidiabetic drug, troglitazone--reason for hope and concern

29 December 2023

2

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.

29 December 2023

3

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Diabetes--a common, growing, serious, costly, and potentially preventable public health problem.

29 December 2023

4

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

29 December 2023

5

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes

29 December 2023

7

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Predisposition to nephropathy in Polynesians is associated with family history of renal disease, not diabetes mellitus.

29 December 2023

8

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Drug administration in patients with diabetes mellitus. Safety considerations

29 December 2023

9

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Improving management of type 2 diabetes mellitus: 5. Thiazolidinediones

29 December 2023

10

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

29 December 2023

11

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

29 December 2023

12

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Mortality risk by body weight and weight change in people with NIDDM. The WHO Multinational Study of Vascular Disease in Diabetes

29 December 2023

13

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Hepatic dysfunction associated with troglitazone

29 December 2023

14

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Hepatotoxicity with thiazolidinediones: is it a class effect?

29 December 2023

15

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes

29 December 2023

16

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans

29 December 2023

17

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes

29 December 2023

18

1 reference

https://api.crossref.org/works/10.1089/152091503763816445

29 December 2023

Identifiers

1 reference

2 December 2017

1 reference